EA201201362A1 - Фармацевтический аэрозольный состав ингибиторов протеаз и его получение - Google Patents

Фармацевтический аэрозольный состав ингибиторов протеаз и его получение

Info

Publication number
EA201201362A1
EA201201362A1 EA201201362A EA201201362A EA201201362A1 EA 201201362 A1 EA201201362 A1 EA 201201362A1 EA 201201362 A EA201201362 A EA 201201362A EA 201201362 A EA201201362 A EA 201201362A EA 201201362 A1 EA201201362 A1 EA 201201362A1
Authority
EA
Eurasian Patent Office
Prior art keywords
aerosol
inhibitors
proteasis
obtaining
aerosol composition
Prior art date
Application number
EA201201362A
Other languages
English (en)
Other versions
EA034991B1 (ru
Inventor
Олег Петрович ЖИРНОВ
Original Assignee
Олег Петрович ЖИРНОВ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Олег Петрович ЖИРНОВ filed Critical Олег Петрович ЖИРНОВ
Publication of EA201201362A1 publication Critical patent/EA201201362A1/ru
Publication of EA034991B1 publication Critical patent/EA034991B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Zoology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

Изобретение относится к медицине и описывает лекарственную композицию водорастворимых белковых или полипептидных соединений из группы ингибиторов протеолитических ферментов для создания аэрозоля с помощью водонерастворимого озонсберегающего пропеллента в аэрозольных устройствах, снабженных дозирующим клапаном. Созданный аэрозольный состав может найти применение при лечении заболеваний, сопровождающихся нарушением протеолитического баланса, таких как респираторные инфекции, включая грипп, кератоконъюнктивиты вирусной и бактериальной этиологии, герпетические поражения слизистых оболочек и кожи, хроническая обструктивная бронхопневмония, астма и др.
EA201201362A 2011-11-03 2012-10-27 Фармацевтический аэрозольный состав ингибитора протеаз EA034991B1 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2011144624A RU2657523C2 (ru) 2011-11-03 2011-11-03 Фармацевтический аэрозольный состав ингибиторов протеаз с озон-сберегающим пропеллентом и его получение

Publications (2)

Publication Number Publication Date
EA201201362A1 true EA201201362A1 (ru) 2013-05-30
EA034991B1 EA034991B1 (ru) 2020-04-15

Family

ID=48192963

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201201362A EA034991B1 (ru) 2011-11-03 2012-10-27 Фармацевтический аэрозольный состав ингибитора протеаз

Country Status (4)

Country Link
EA (1) EA034991B1 (ru)
GB (1) GB2511011A (ru)
RU (1) RU2657523C2 (ru)
WO (1) WO2013066214A2 (ru)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2711080C2 (ru) * 2015-06-15 2020-01-15 Олег Петрович Жирнов Комбинированный аэрозольный состав на основе ингибиторов протеаз и его получение
WO2022216172A1 (ru) * 2021-04-06 2022-10-13 Андрей Александрович ИВАЩЕНКО Водная апротинин-содержащая противовирусная фармацевтическая композиция

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2656944B2 (ja) * 1987-04-30 1997-09-24 クーパー ラボラトリーズ タンパク質性治療剤のエアロゾール化
RU2054180C1 (ru) * 1991-08-21 1996-02-10 Жирнов Олег Петрович (н/п) Способ лечения вирусных респираторных инфекций
US6524557B1 (en) * 1994-12-22 2003-02-25 Astrazeneca Ab Aerosol formulations of peptides and proteins
US20010006939A1 (en) * 1997-10-03 2001-07-05 Ralph W. Niven Secretory leukocyte protease inhibitor dry powder pharmaceutical compositions
US6849263B2 (en) * 1998-12-21 2005-02-01 Generex Pharmaceutical Incorporated Pharmaceutical compositions for buccal delivery of pain relief medications
US6294153B1 (en) * 1998-12-21 2001-09-25 Generex Pharmaceuticals, Inc. Aerosol pharmaceutical formulation for pulmonary and nasal delivery
JP2003501404A (ja) * 1999-06-04 2003-01-14 デルルックス ファーマシューティカル コーポレイション 薬剤の脱水粒子からなる製剤およびこれの調製方法
WO2002043750A2 (en) * 2000-12-01 2002-06-06 Battelle Memorial Institute Method for the stabilizing of biomolecules (e.g. insulin) in liquid formulations
GB0507577D0 (en) * 2005-04-14 2005-05-18 Novartis Ag Organic compounds
RU2356537C2 (ru) * 2007-07-25 2009-05-27 Закрытое Акционерное Общество (ЗАО) "Пульмомед" Фармацевтический состав дозированных аэрозолей, содержащий противоастматические лекарственные средства в виде суспензий, растворов, эмульсий, растворов и эмульсий
RU2425691C1 (ru) * 2010-07-15 2011-08-10 ВАКЕ спол с.р.о. Аэрозольный препарат на основе апротинина для лечения вирусных респираторных инфекций

Also Published As

Publication number Publication date
EA034991B1 (ru) 2020-04-15
WO2013066214A3 (ru) 2013-08-22
RU2657523C2 (ru) 2018-06-14
GB201409877D0 (en) 2014-07-16
WO2013066214A2 (ru) 2013-05-10
GB2511011A (en) 2014-08-20
RU2011144624A (ru) 2013-05-10

Similar Documents

Publication Publication Date Title
AU2018201997B2 (en) Peptides which inhibit activated receptors and their use in cosmetic or pharmaceutical compositions
BR112014007223A2 (pt) derivados de estra-1,3,5(10),16-tetraeno-3-carboxamida, processos para sua preparação, preparações farmacêuticas compreendendo os mesmos e seu uso para preparar medicamentos
EA201690541A1 (ru) Сухой порошковый препарат, содержащий ингибитор фосфодиэстеразы
CL2014000122A1 (es) Compuestos derivados de indazol, inhibidores de janus quinasa (jak); composicion farmaceutica que los comprende; y su uso para tratar rinitis alergica, congestion nasal, asma, bronquitis cronica, artritis, insuficiencia cardiaca, colitis ulcerativa, infeccion viral y bacteriana, cancer y alzheimer, entre otras enfermedades.
PH12020551709A1 (en) Antiviral immunotropic agent for the treatment of acute respiratory viral infections
JP2015534562A5 (ru)
WO2013021199A3 (en) Eutectic mixture for pulmonary administration
BR112014015845A8 (pt) derivados de azetidina, composições farmacêuticas e seu uso
BR112014027681A2 (pt) preparações de agentes terapêuticos hidrofóbicos, métodos de fabricação e uso dos mesmos
ECSP10010216A (es) 4-(4-ciano-2-tioaril)dihidropirimidinonas y su uso
BR112014007694A2 (pt) 1-pirazolil-3-(4-((2-anilinopirimidin-4-il)óxi)naftaleno-1-il)ureias como inibidores de p38 map cinase
BR112014031291A2 (pt) válvula dosimetrada para dispensação
CL2012001836A1 (es) Compuestos de pirazol, antagonista de crth2; composicion farmacéutica; uso en el tratamiento de trastornos inflamatorios, infecciosos, inmunoreguladores, enfermedades respiratorias, gastrointestinales o dolencias, entre otros.
GB2503066A8 (en) Combination pharmaceutical composition and methods of treating and preventing the infectious diseases
BR112014011345A2 (pt) partículas tipo vírus da influenza (vlps) compreendendo nicotiana tabacum produzida por hemaglutinina
Li et al. Cappariloside A shows antiviral and better anti-inflammatory effects against influenza virus via regulating host IFN signaling, in vitro and vivo
EA201201393A1 (ru) Ингалятор, разработанный для доставки лекарственного средства в виде сухого порошка
EA201201362A1 (ru) Фармацевтический аэрозольный состав ингибиторов протеаз и его получение
PH12018502522A1 (en) Beta-hairpin peptidomimetic with elastase inhibitory activity and aerosol dosage forms thereof
BR112015028890A2 (pt) derivados de piridona para o tratamento de infecções virais e outras doenças
MX2018013475A (es) Acido carboxilico para tratar/prevenir congestion nasal.
EA201500486A1 (ru) Фармацевтическая композиция для аэрозольного применения и ее получение
EA201890789A1 (ru) Содержащая цинеол композиция для лечения заболеваний носа
WO2007089562A3 (en) Compositions and methods for the treatment of viral infections
Rousse et al. Innovative scientific concept of topical virus glycoprotein inhibitors incorporated in hyperosmotic glycerol revolutionizes future prospects in the treatment of viral and bacterial throat infections

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): TJ TM